mevalonic acid and Coronary Artery Disease

mevalonic acid has been researched along with Coronary Artery Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chaudhri, K; Gnanenthiran, SR; McOrist, NS; Saunders, SL; Shalaby, G	1
Maeda, K; Minami, M; Yasunari, K; Yoshikawa, J	1

Other Studies

2 other study(ies) available for mevalonic acid and Coronary Artery Disease

Article	Year
Do bisphosphonates and RANKL inhibitors alter the progression of coronary artery calcification? A systematic review and meta-analysis protocol. BMJ open, 2022, 10-07, Volume: 12, Issue:10 Topics: Calcium; Coronary Artery Disease; Denosumab; Diphosphonates; Humans; Meta-Analysis as Topic; Mevalonic Acid; Systematic Reviews as Topic	2022
HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress. Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:6 Topics: Antioxidants; Cell Movement; Cells, Cultured; Coronary Artery Disease; Coronary Vessels; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Isoenzymes; Lysophosphatidylcholines; Mevalonic Acid; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Oxidative Stress; Phospholipase D; Pravastatin; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Protein-Tyrosine Kinases; Simvastatin	2001

Article

Year

Do bisphosphonates and RANKL inhibitors alter the progression of coronary artery calcification? A systematic review and meta-analysis protocol.

BMJ open, 2022, 10-07, Volume: 12, Issue:10

Topics: Calcium; Coronary Artery Disease; Denosumab; Diphosphonates; Humans; Meta-Analysis as Topic; Mevalonic Acid; Systematic Reviews as Topic

2022

HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress.

Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:6

Topics: Antioxidants; Cell Movement; Cells, Cultured; Coronary Artery Disease; Coronary Vessels; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Isoenzymes; Lysophosphatidylcholines; Mevalonic Acid; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Oxidative Stress; Phospholipase D; Pravastatin; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Protein-Tyrosine Kinases; Simvastatin

2001